7 REASONS PRINCIPAL INVESTIGATORS APPRECIATE MOSIO
For many principal investigators, Mosio is worth the investment. Based on many web-based surveys and interviews, our software has helped these research professionals save time and money by automating their many everyday tasks like informing participants of new information, ensuring optimal compliance, sending customized messages, and much more! In order for the team to perform at their best, the PI needs innovative and efficient tools. Here is a more detailed description of reasons why principal investigators appreciate using Mosio in their studies.
Trending PR+R News:
How Helpful are Historical Subject Recruitment Rates?
Whenever a new clinical study is in planning stage, the operational teams are busy trying to locate recruitment data from similar previous studies to project the number of sites needed, forecast study timelines, and make other seminal decisions. The problem is, trials are never identical. Apart from well documented differences (inclusion/exclusion criteria, study design, study footprint, etc.) there are less tangible, but no less important, considerations. Read more for details.
FDA Issues New Guides on Use of Electronic Health Information in Clinical Trials
In guidelines released July 18, the FDA encourages sponsors and investigators to use approved EHR or electronic capture data capture (EDC) systems to exchange key information, noting that doing so can dramatically speed up information sharing and precision.
Lessons In Patient-Centricity From Rare Disease Clinical Trials
What can patient-centricity look like in the clinical trial arena? Well, there’s already a model that exhibits many of the elements of patient-centricity in clinical trials, and it’s in the rare diseases space.
The essential, central role and value of patient engagement in orphan drug development exemplifies the benefits of patient-centricity. Discover the strategies being adopted to enable adoption of a patient-centric approach to the broader drug development industry.
Recruitment and retention: How can we do better?
Researchers from the University of Liverpool’s Department of Biostatistics conducted a study, Identifying research priorities for effective retention strategies in clinical trials, focusing on the on the UK clinical trial landscape to identify prevalent retention methodologies currently in practice, and evaluate where the industry’s priorities lie in examining the effectiveness of such practices to better understand the impact that failures in recruitment and retention of trial participants can cause.
Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain
Building clinical trials around patients in their homes and community through remote visits and monitoring could enhance recruitment and increase convenience for participants. This study evaluated different trial settings, a decentralized arm via telemedicine center (virtual study conduct), a conventional arm via health clinic (onsite study conduct) and a mixed model arm. Faster recruitment and improved access to patients was observed in the decentralized arm, supporting broader adoption of the decentralized model in clinical trials.
New Guidance for Multiregional Clinical Trials
Multiregional trials have historically been used as a quick way to recruit participants with rare diseases or in special populations (like children or the elderly) or for large-scale studies (such as vaccine safety and effectiveness). But sponsors increasingly have found they’re an efficient way to get more drugs to more people — and they’re fast becoming the preferred choice for investigating new meds in today’s global market. See more for the FDA’s newly issued guidelines designed to help researchers navigate sometimes conflicting regional requirements and differences in global clinical trials.
Are you looking to improve participant engagement, increase retention, integrate text-based interventions, or collect data in your research? If so, contact us for a free consultation, or you can get quick access to our pricing guide here.
Want to receive more exclusive industry insights?
Join the Patient Recruitment and Retention (PR+R) LinkedIn Group.